P3 Health Partners (NASDAQ:PIII - Get Free Report) is expected to be announcing its Q1 2025 earnings results before the market opens on Thursday, May 15th. Analysts expect the company to announce earnings of ($5.00) per share and revenue of $362.09 million for the quarter.
P3 Health Partners (NASDAQ:PIII - Get Free Report) last issued its earnings results on Thursday, March 27th. The company reported ($16.00) earnings per share for the quarter, missing analysts' consensus estimates of ($8.50) by ($7.50). The business had revenue of $370.69 million during the quarter, compared to the consensus estimate of $378.88 million. P3 Health Partners had a negative return on equity of 71.31% and a negative net margin of 6.95%. On average, analysts expect P3 Health Partners to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
P3 Health Partners Trading Down 2.6%
PIII stock traded down $0.23 during mid-day trading on Monday, reaching $8.48. The company's stock had a trading volume of 784 shares, compared to its average volume of 20,523. The company has a market cap of $60.90 million, a price-to-earnings ratio of -10.10 and a beta of 0.94. The business's 50 day moving average price is $8.82 and its 200 day moving average price is $10.78. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 1.11. P3 Health Partners has a 12 month low of $7.00 and a 12 month high of $34.50.
Analyst Upgrades and Downgrades
Separately, Lake Street Capital reduced their price objective on P3 Health Partners from $50.00 to $20.00 and set a "buy" rating for the company in a research note on Monday, April 21st.
View Our Latest Stock Analysis on P3 Health Partners
About P3 Health Partners
(
Get Free Report)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
Further Reading
Before you consider P3 Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.
While P3 Health Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
